USPTO serial 85312281
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | syringes; insulin syringes; needles; insulin needles; lancets; safety syringes; tuberculin syringes; hypodermic needles; aluminum hub needles; radiopaque aluminum hub needles; multi-sample needles; multi-sample luer holders; multi-sample luer adapters; injection plugs; blood collection sets; safety blood collection sets; IV cannulas; IV catheters; spinal needles; dental needles; central venous catheters; safety scalp vein; scalp vein sets; huber infusion sets; huber needles; non-DEHP safety huber infusion sets; tracheal tubes; silicon coated latex foley catheters; all silicon foley catheters; nebulizers with mask; venturi masks; AV fistulas; pressure bandages; latex examination gloves; surgical blades; disposable scalpels; IV administration sets; filtered IV administration sets; burrette sets; pen needles; allergy syringes; curved tip syringes; culinary syringes; safety huber infusion sets; mini safety huber infusion sets; U-40 insulin syringes; polypropylene hub hypodermic needles; drenching syringes; bulb syringes; feeding tubes; blood collection sets; Apparatus for blood analysis; Apparatus for taking blood; Apparatus for taking blood samples; Blood component separation apparatus for medical purposes; Blood drawing apparatus; Blood testing apparatus | ACTIVE | Aug 1, 1987 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 21, 2012 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 20, 2012 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 24, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2011 | NWAP | NEW APPLICATION ENTERED | — |